The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...

Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and ...

Stoke Therapeutics is developing a drug designed to reduce seizures and restore some of their lost developmental function.

Swiss pharma Roche is staying in lockstep with Eli Lilly, expanding its artificial intelligence offerings and Nvidia ...

With fresh billions unlocked in the 2026 U.S. budget and mission‑driven family offices recalibrating after a “nuclear winter, ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Viking Therapeutics develops clinical-stage therapies for metabolic and endocrine disorders, aiming to address unmet medical ...

The latest biotech industry insights, including a publication demonstrating dramatic lifespan extension in aging mouse models ...

Damian Garde joins Allison, Adam, and Elaine to discuss his article about Boris Nikolic, a well-connected biotech investor ...

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced it has been named “Overall Immunology Company of the Year” in the fifth annual BioTech ...